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epatocellular carcinoma (HCC), one of the most fatal malignancies, is particularly prevalent in Egypt; there are deficiencies in knowledge concerning HCC and its risk factors. Hepatitis C viral infections are highly prevalent in Egypt, pesticides are very commonly used, and diets are often contaminated by aflatoxin, especially in rural areas (Saleh et al., 2015) . Human hepatocellular carcinoma (HCC) is a heterogeneous disease, driven by different risk factors and presenting diverse clinicopathological features and outcomes (De Ponti et al., 2015) . HCC is one of the major malignant diseases in many healthcare systems. The growing number of new cases diagnosed each year is nearly equal to the number of deaths from this cancer (Galun et al., 2015) . Chronic low-grade inflammation alters both innate and adaptive immune responses; as a result tolerogenic environment is established in damaged organ. Up to date, incomplete understanding of HCC pathogenesis and the extend of biomarker variability among patients represent the major obstacle for early diagnosis and for the choice of effective treatment (Kikodze et al., 2015) . The majority of hepatocellular carcinoma occurs over pre-existing chronic liver diseases that share cirrhosis as an endpoint. In the last decade, a strong association between lifestyle and hepatocellular carcinoma has become evident. Abundance of energy-rich food and sedentary lifestyles have caused metabolic conditions such as obesity and diabetes mellitus to become global epidemics (Saran et al., 2016) . Cytokines are humoral immunomodulatory proteins or glycoproteins which control or modulate the activities of target cells, generally those within the haematopoietic system. They act on target cells by binding to specific cytokine receptor ligands, initiating signal transduction and second messenger pathways within the target cell (Bidwell et al., 1999) . Recent advances in genetics have made it possible to study the role of cytokine gene polymorphisms in HCC development (Bunnapradist and Jordan, 2000) . In recent years cytokines and their receptors have H been shown to be highly polymorphic. Polymorphisms in these genes have been associated with a number of immune diseases (Keen, 2002) , and associated with high and low cytokine production and may modulate the magnitude of alloimmune responses during HCC (Hoffmann et al., 2002; Ben-Ari et al., 2004) . Chronic hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC), and the HBV X (HBx) gene plays a critical role in the molecular pathogenesis of HBVrelated HCC (Zhu et al., 2007) . Cytokine gene single nucleotide polymorphisms (SNPs) are involved in the genesis and progression of hepatocellular carcinoma (HCC) (Bei et al., 2014) . Interleukin 10 (IL-10) is a pleiotropic cytokine designated as an immunosuppressive molecule, but may act as an immunostimulant factor in cancer development and progression (Hiroki et al., 2015) . The T helper cells (Th1 and Th2) CD4_T-cells differ in cytokine expression: Th1 cells produce interleukin (IL)-1β, interferon gamma (IFN-γ) and TNF are generally referred to as proinflammatory, whereas Th2 cells express IL-4, -5, -6, -10 and -13, induce antiinflammatory responses, This cytokine heterogeneity is not restricted to CD4_T-cells, as other cell types also contribute to the secretion of regulatory cytokines (Moran et al., 2006) . SGOT and SGPT are highly sensitive markers of liver damage due to various diseases or injury. Conversely, individuals developing chronic hepatitis C infection have minor elevations in their SGOT and SGPT levels, whereas, their liver is injured or damaged substantially by the infection even leading to scarring (cirrhosis) from ongoing liver infection and inflammation (Hamza et al., 2015 
MATERIAL AND METHODS

Study population
HCC participants for this study were Egyptian patients and consisted of 75 (55 males and 20 females), HCC patients were randomly selected from health screening program participants to exclude those with a history of cancer and other medical diseases and 75 cancer-free controls, who had no personal or family history of hepatocellular carcinoma,from May 2012 to March 2014, all patients were selected from the outpatient clinic, Internal Department Of Specialized Medical Hospital in Mansoura University. All HCC patients were diagnosed on the basis of histology or the combination of typical radiological findings of HCC, and underwent surgery in medical hospital in Mansoura University. The HBsAg and anti-hepatitis C virus (HCV) antibody were tested by microparticle enzyme immunoassays using commercial assay kits, which were used to determine the infec-tion status of hepatitis B or hepatitis C. Clinical characteristics data as well as related risk factors, including gender, age, serum SGPT (ALT), SGOT (AST, albumin), Total billrubin, family history of HCC and HBV, HCV serological markers, were summarized (Table 2) .
Serologic testing
Serum levels of albumin, total bilirubin, direct bilirubin, alanine aminotransferase (ALT or SGPT), and aspartate aminotransferase (AST or SGOT) were tested. The diagnosis of cirrhosis was based on the presence of clinical manifestations of portal hypertension such as varices, encephalopathy, or ascites; Biochemical abnormalities including elevated serum bilirubin, serum albumin, or prothrombin; and obvious morphologic change of the liver detected by hepatic imaging such as ultrasonography.
HCC diagnosis
The diagnosis of HCC was made after reviewing images generated with several imaging modalities. Nodules larger than 1 cm found in the ultrasound screening of a cirrhotic liver were investigated further with either 4 phase multidetector computed tomography (CT) scan or dynamic contrast enhanced magnetic resonance imaging (MRI). If the appearances were typical of HCC, namely, hypervascular in the arterial phase with washout in the portal venous or delayed phase, the lesion was diagnosed as HCC. If the findings were not characteristic or the vascular profile was not typical, a second contrast enhanced study with the other imaging modality was performed or the lesion was biopsied. All patients were confirmed not to have other cancers in an initial screening examination.
Polymorphism genotyping
Genomic DNA was extracted from whole EDTA-treated peripheral blood using a QIAamp Blood Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. SNPs were analyzed in three cytokines (IL-1β, TNF-α and IL-10) for genotype assignment. Amplification was performed in GeneAmp PCR System 9700 termocycler (Applied Biosystems, Singapore) with 100 ng of genomic DNA, 25 pmol of each primer, 200 μM total dNTP, 1.5 mM MgCL 2 , PCR buffer and 2.5 U Taq DNA polymerase (Promega, Madison, WI, USA). The following cycling conditions were used: 95C for 5 min, followed by 35 cycles of 94C for 60s, (55C for TNF-α, IL-1β and 60C for IL-10) for 30s and 72C for 60s, with a final extension at 72C for 10 min. Amplification products (15 μl) were digested with 2 units different restriction enzymes (New England Biolabs Ltd., Beijing, China) at 37C for over 4 h to detect allele (Table 1) , showed Primers, PCR sizes and restriction enzymes used for analyses the IL-10, TNF-α and IL-1β gene polymorphisms and analyzed on a 2% agarose gel. DNA products were visualized by ethidium bromide staining. The cytokines showed two fragments (homozygous for the allele), while its homologue were undigested and resulted in a single band (homozygous for allele). The presence of all three fragments defined heterozygotic individuals.
Statistical analysis
Data were fed to the computer and analyzed using IBM SPSS software package version 20.0. [40] . Qualitative data were described using number and percent.
Quantitative data were described using range (minimum and maximum), mean, standard deviation and median. Comparison between different groups regarding categorical variables was tested using Chisquare test (Campbell, 2007) . When more than 20% of the cells have expected count less than 5, correction for chi-square was conducted using Monte Carlo correction.
The distributions of quantitative variables were tested for normality using Kolmogorov-Smirnov test, Shapiro-Wilk test and D'Agstino test, if it reveals normal data distribution, parametric tests was applied.
If the data were abnormally distributed, non-parametric tests were used. For normally distributed data, comparison between two independent populations was done using independent t-test. For abnormally distributed data, comparison between two independent populations were done using Mann Whitney test. Odd ratio (OR) and 95% Confidence Interval were used to calculate the ratio of the odds of an event occurring in one patient group to the odds of it occurring in the control group. Significance of the obtained results was judged at the 5% level.
RESULTS AND DISCUSSION
Demographic and clinical information of patients and controls
The general demographic characteristics of the subjects and the most commonly enzymes used indicators of liver (hepatocellular) damage are the alanine aminotransferase (ALT) and aspartate aminotransferase (AST), formerly referred to as the SGPT and SGOT showed in Table ( 2). There were 75 HCC patients, 55 were men and 20 were women, with an age ranged from 40 to 70 years and 75 healthy controls, 49 were men and 26 were women, with an age ranged from 40 to 75 years, without any history of liver disease. There were no significant differences between HCC cases and cancer-free controls with regarded to gender and age distribution. Patients with HCC not only had lower serum albumin level (P = 0.001) but had high level in other enzymes in serum (P = 0.001) compare with control, No significant differences of gender and age were detected between the patients and controls. Significant differences observed of ALT enzyme (Z=8.168 serum albumin level (P = 0.001) and ALT (P = 0.037), but also had high prothrombin (P = 0.001) and high AST.
Cytokine genotyping
Genotypic distributions of IL-1β [single nucleotide polymorphisms (SNPs)], (TNF-α) and IL-10 for the patients group and control group separately, the observed genotype distribution in the controls did not differ from those expected from Mann Whitney equilibrium (P > 0.05). and IL-1β 511 (C-T) were observed between the patient and control groups. In contrast, significant differences of SNP genotype and allele distribution at the other cytokine TNF-α-308 G/A was detected. These were summarized as follows: the frequencies of 1082-G/A genotypes of IL-10 in our population are shown in Table ( Yang et al., 2011) . The ability of pro-and anti-inflammatory cytokine levels to predict patient outcome has been studied. IL-10 levels were significantly higher in HCC than in healthy individuals (Critelli et al., 2015; Douglas et al., 2008) , and a multivariate analysis implied that IL-10 may be a predictor of the postresection outcome of HCC patients (He and Hu, 2001). IL-10 is a multifunctional anti-inflammatory cytokine that down regulates cell-mediated immune responses and cytotoxic inflammatory responses, whose effects are directed mainly against functions of mononuclear cells (Kockar et al., 2012; Ye et al., 2011) . The polymorphisms in IL-10 have been extensively studied in HCC. The results are conflicting, the 1082 G/A polymorphism associated with reduced plasma levels (Abbas et al., 2005) , the association of IL-10 cytokine SNPs and the risk for developing HCC are less clear. A polymorphism of IL-10 in 1078 chronic HBV patients and HCC was strongly associated with HCC and with an increased production of IL-10 (Liu et al., 2015) . The frequency of susceptibility increased in order from chronic hepatitis to liver cirrhosis and HCC among HBV patients (Zhu et al., 2015) . IL-10 polymorphisms (-1082G/A, -819C/T) were associated with reduced plasma IL-10 levels in a study of 77 patients with chronic HBV, and a separate study of 236 Japanese patients with HBV infection, no genetic difference was observed in IL-10 (-1082, -819, -592) (Renzulli and Golfieri, 2015; Heneghan et al., 2003) . Pro-inflammatory IL-1β was shown to be elevated in HCC patients compared with healthy individuals (Huang et al., 1999) . IL-1β has also been measured in HCC undergoing resection (Sato et al., 1996) . Higher IL-1β was found in cirrhotic patients when compared with healthy individuals or preoperative patients and increased postoperatively (Sato et al., 1996) . The distribution of alleles may have accounted for the susceptibility of the Egyptian population to develop HCC. IL-1β -511 allele, which may be associated with high IL-1β production in the liver, is a genetic marker for the development of HCC in chronic hepatitis B patients in Thai population (Hirankarn et al., 2006) . The IL-1β -511 genotype T/T was a significant risk factor for HCC. The C-511T-IL-1β polymorphism was also examined in Thai patients with chronic HBV. In this cohort, the IL-1β -511 genotype C/C was found to be significantly higher in patients with HCC against healthy individuals (Popko et al., 2008) . TNF-α protein induces the expression of adhesion molecules, facilitating the inva-sion of metastatic tumor cells (Bortolami et al., 2002) . TNF-α was high in HCC and metastases to the liver before operation compared with healthy individuals and increased postoperatively (Nakazaki, 1992; Bortolami et al., 2002; Zhu et al., 2005) . TNF-α expression was elevated in HCC patients, the levels of the TNF-α were higher in HCC patients when compared with healthy individuals (Nakazaki, 1992; Bortolami et al., 2002; Zekri et al., 2005) . An increased level of TNF-α was also shown to correlate with hepatic inflammation, necrosis, and hepatic failure (Nagai et al., 2014) . The level of this cytokine increased postoperatively and correlated with postoperative and hepatic failure (Kato et al., 2003; Yang et al., 2015) . The TNF-α (-308) SNP in the promoter region of the gene, which includes TNF-α1 (-308G) and TNF-α2 (-308A) alleles, is associated with cancer susceptibility and induced expression of TNF-α. In a case study, 74 HCC and 89 healthy individuals were assayed for their -308 genotype (Popko et al., 2008) . Carriage of the TNF-α allele was associated with an increased risk (3.5 odds ratio) of HCC, the TNF-α allele was therefore a significant predictor of HCC (Akkiz et al., 2009) , In our study 75 HCC from Egypt cohort and 75 controls who were healthy individuals. As shown in Table ( , and IL-1β 511 in HCC progression and TNF-α allele was associated with high increased risk of HCC was found in Egyptian patients. Consequently, the G/A polymorphism may play a role in altered TNF-α gene expression in patients. The G/G genotype at -308 was found in all carriers with HCC but only in 78% of healthy individuals. The distribution in the HCC group was significantly different from the healthy group (Lertwittayapon et al., 2012) . Therefore, TNF-α may inhibit carcinogenesis through cytotoxic induction; however, under certain circumstances, this cytokine can promote this process. So the TNF-α polymorphism may therefore be a genetic marker for the development of hepatitis-related HCC.
SUMMARY
Polymorphisms in cytokine genes responsible for inflammatory and immune responses are associated with risk of hepatocellular carcinoma (HCC) 
